ACYCLOVIR SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Acyclovir Sodium patents expire, and when can generic versions of Acyclovir Sodium launch?
Acyclovir Sodium is a drug marketed by Apothecon, Chartwell Injectable, Dr Reddys, Eugia Pharma, Eurohlth Intl Sarl, Fresenius Kabi Usa, Hikma, Hospira, Pharmobedient, Slate Run Pharma, Teva Parenteral, and Zydus Pharms. and is included in nineteen NDAs.
The generic ingredient in ACYCLOVIR SODIUM is acyclovir sodium. There are fifty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acyclovir Sodium
A generic version of ACYCLOVIR SODIUM was approved as acyclovir sodium by FRESENIUS KABI USA on May 13th, 1998.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ACYCLOVIR SODIUM?
- What are the global sales for ACYCLOVIR SODIUM?
- What is Average Wholesale Price for ACYCLOVIR SODIUM?
Summary for ACYCLOVIR SODIUM
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 19 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 8 |
| Patent Applications: | 598 |
| Drug Prices: | Drug price information for ACYCLOVIR SODIUM |
| DailyMed Link: | ACYCLOVIR SODIUM at DailyMed |
US Patents and Regulatory Information for ACYCLOVIR SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms | ACYCLOVIR SODIUM | acyclovir sodium | INJECTABLE;INJECTION | 206606-001 | Jun 13, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apothecon | ACYCLOVIR SODIUM | acyclovir sodium | INJECTABLE;INJECTION | 074897-002 | Feb 27, 1998 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | ACYCLOVIR SODIUM | acyclovir sodium | INJECTABLE;INJECTION | 074663-001 | Apr 22, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
